New York State Psychiatric Association

NYSPA Issues Press Release on SAFE Act Reporting Requirements

Recently, NYSPA has been mentioned in several newspaper articles regarding the SAFE Act reporting requirements. 

Read more...
 

Dr. Kroplick Named NYSOM's Physician of the Year

Lois Kroplick Receiving Award

NYSPA congratulates Lois Kroplick, D.O. on being named 2014 Physician of the Year Award by the New York State Osteopathic Medical Society. The award was presented on February 21st at the President’s Reception during the 2014 Regional Osteopathic Convention.

Dr. Kroplick is the first psychiatrist to have received this honor. Click here to view a copy of Dr. Kroplick's acceptance speech.  

 

NYSPA Provides Testimony on SAFE Act Reporting Requirement 

 
On May 31, 2013, NYSPA presented testimony at a Senate hearing regarding the impact of the SAFE Act mental health reporting requirement. 

Read more...
 

RxNT Named as NYSPA Endorsed eRx Vendor

NYSPA is pleased to announce that it has endorsed Networking Technology, Inc., doing business as RxNT, as its preferred vendor for electronic prescribing software. 

RxNT is a leading software solutions provider that offers a stand-alone electronic prescribing platform for both controlled and non-controlled medications. RxNT is DEA-certified for electronic prescribing of controlled substances and is SureScripts Award winning system. 

For additional information about RxNT, visit their website at www.RxNT.com, call 1-800-943-7968, ext. 3, or send an e-mail to sales@rxnt.com. For a copy of the RxNT registration materials, please click here

 

PQRS Clarification

In response to our recent website article on the new PQRS 2015 payment reduction, NYSPA has received several inquiries from members regarding the use of Measure #9 (Major Depressive Disorder (MDD): Antidepressant Medication During Acute Phase for Patients with MDD)

Read more...
 
<< first < Prev 1 2 3 4 5 6 7 8 9 10 Next > last >>

Page 2 of 12